Reducing ryanodine receptor open probability as a means to abolish spontaneous Ca2+ release and increase Ca2+ transient amplitude in adult ventricular myocytes

Circ Res. 2006 May 26;98(10):1299-305. doi: 10.1161/01.RES.0000222000.35500.65. Epub 2006 Apr 13.

Abstract

The aim of this work was to investigate whether it is possible to remove arrhythmogenic Ca2+ release from the sarcoplasmic reticulum that occurs in calcium overload without compromising normal systolic release. Exposure of rat ventricular myocytes to isoproterenol (1 micromol/L) resulted in an increased amplitude of the systolic Ca2+ transient and the appearance of waves of diastolic Ca2+ release. Application of tetracaine (25 to 50 micromol/L) decreased the frequency or abolished the diastolic Ca2+ release. This was accompanied by an increase in the amplitude of the systolic Ca2+ transient. Cellular Ca2+ flux balance was investigated by integrating Ca2+ entry (on the L-type Ca2+ current) and efflux (on Na-Ca2+ exchange). Isoproterenol increased Ca2+ influx but failed to increase Ca2+ efflux during systole (because of the abbreviation of the duration of the Ca2+ transient). To match this increased influx the bulk of Ca2+ efflux occurred via Na-Ca2+ exchange during a diastolic Ca2+ wave. Subsequent application of tetracaine increased systolic Ca2+ efflux and abolished the diastolic efflux. The increase of systolic efflux in tetracaine resulted from both increased amplitude and duration of the systolic Ca2+ transient. In the presence of isoproterenol, those Ca2+ transients preceded by diastolic release were smaller than those where no diastolic release had occurred. When tetracaine was added, the amplitude of the Ca2+ transient was similar to those in isoproterenol with no diastolic release and larger than those preceded by diastolic release. We conclude that tetracaine increases the amplitude of the systolic Ca2+ transient by removing the inhibitory effect of diastolic Ca2+ release.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism*
  • Calcium Channels, L-Type / metabolism
  • Calcium Channels, L-Type / physiology
  • Cardiotonic Agents / pharmacology
  • Diastole
  • Heart Ventricles
  • Isoproterenol / pharmacology
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism*
  • Patch-Clamp Techniques
  • Rats
  • Rats, Wistar
  • Ryanodine Receptor Calcium Release Channel / metabolism*
  • Sarcolemma / metabolism
  • Systole
  • Tetracaine / pharmacology

Substances

  • Calcium Channels, L-Type
  • Cardiotonic Agents
  • Ryanodine Receptor Calcium Release Channel
  • Tetracaine
  • Isoproterenol
  • Calcium